Conan Young, Ph.D.

Conan has over 20 years of experience as an R&D leader serving the biopharmaceutical and medical device industry driving the non-clinical, manufacturing and technical development and commercialization of advanced biologics, implantable medical devices and combination products. Prior to supporting BCVG, Conan was Vice President, R&D at Wright Medical (now Stryker) leading recombinant PDGF-BB product development strategy, quality control and drug substance manufacturing to treat orthopedic indications. Previously, he served as Director, Research at MiMedx leading non-clinical development of amniotic tissue allograft for dermal wound, surgical and orthopedic indications. Conan spent 5 years serving as Director, R&D at Shire Pharmaceuticals (previously Advanced BioHealing) leading nonclinical development and manufacturing tech transfer of human allogeneic cell therapies for dermal wound care and vascular repair. He holds a Ph.D.(Microbiology) from the University of British Columbia, a MSc. (Microbial Biotechnology) from the University of Waterloo, and a B.Sc. (Cellular, Molecular and Microbial Biology) from the University of Calgary.